{"id":2381,"date":"2020-12-10T22:11:05","date_gmt":"2020-12-10T22:11:05","guid":{"rendered":"https:\/\/biotechsa.com\/2\/?p=2381"},"modified":"2026-03-10T12:59:23","modified_gmt":"2026-03-10T18:59:23","slug":"interview-with-dr-jay-hoofnagle-on-the-discovery-of-hepatitis-c-and-progress-in-preventing-and-treating-chronic-infection","status":"publish","type":"post","link":"https:\/\/biotechsa.com\/2\/noticias\/interview-with-dr-jay-hoofnagle-on-the-discovery-of-hepatitis-c-and-progress-in-preventing-and-treating-chronic-infection\/","title":{"rendered":"Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection."},"content":{"rendered":"
<\/span><\/div>

Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the\u00a0<\/span>Journal<\/i>.<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>

\"\"<\/a><\/p>\n<\/div><\/div><\/div>

<\/a>Audio Interview<\/a><\/h3>\n

Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.\u00a0(14:28)<\/a><\/p>\n<\/div><\/div><\/div><\/div>

The bibliographic file:<\/strong><\/p>\n

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https:\/\/www.nejm.org\/action\/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>

\n\n